The 1950s are widely recognized as one of the most important decades in biology. This is, in large part, due to the discovery of the structure of DNA and the launch of the field of molecular biology. At roughly the same time, less flashy discoveries were made that were, arguably, just as important. Several polymerases were identified. In 1956, Arthur Kornberg discovered DNA polymerase. In 1959, Severo Ochoa discovered RNA polymerase. And also in 1959, Frederick James Bollum d

Phase 1b study designed to determine the safety and dose of NUV-868 in combination with olaparib or enzalutamide for the treatment of advanced solid tumors NEW YORK--(BUSINESS WIRE)-- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced it has dosed the first patient in a Phase 1b study of its BD2-selective BET inhibitor, NUV-868, in comb

- Study will assess the safety, efficacy and engraftment of FB-001 for the treatment of enteric hyperoxaluria, a serious metabolic disorder – - FB-001 is a rationally designed consortium of 148 defined bacterial strains with unprecedented diversity, representing a complete microbiome replacement – SOUTH SAN FRANCISCO, Calif., Dec. 8, 2022 /PRNewswire/ -- Federation Bio, a biotechnology company pioneering bacterial cell therapies, today announced that investigators have admini